Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Enveric Biosciences develops neuroplastogenic small-molecule therapeutics targeting mental health disorders such as depression, anxiety, and addiction. Utilizing proprietary platforms like the Psybrary, the company focuses on novel psychedelic-inspired compounds with potential therapeutic benefits without hallucinogenic effects. It advances preclinical and clinical research, seeks regulatory approvals, and collaborates with academic and industry partners to bring innovative neuropsychiatric treatments to market.
This description was generated via AI from an annual report. Updated about 1 year ago.